WellStack has acquired DeLorean AI, a healthcare-focused artificial intelligence company specializing in predictive analytics, risk stratification, and action-oriented decision support.
The acquisition combines WellStack’s agentic healthcare data platform and analytics capabilities with DeLorean AI’s predictive intelligence technology.
Together, the companies aim to create an end-to-end decision intelligence platform that helps healthcare organizations move from aggregating data to identifying risks, determining recommended actions and measuring the results of interventions.
WellStack is positioning the combined platform as a precision intelligence operating system for healthcare.
The company said healthcare organizations have invested heavily in collecting and organizing clinical, claims and operational data, but many still struggle to determine which patients, workflows or financial risks require immediate attention.
DeLorean AI’s technology continuously evaluates healthcare data to identify emerging risks, predict potential adverse events and recommend evidence-based next actions for clinical and operational teams.
By integrating those capabilities with WellStack’s data platform, customers can move from understanding what happened to predicting what could happen next and determining what actions to take.
The combined platform is designed to help healthcare organizations identify patient and operational risks earlier and intervene more effectively.
WellStack also plans to use DeLorean AI’s technology to accelerate product development and expand the intelligence available through its AI-enabled user experience.
The companies said existing client case studies have demonstrated improvements in areas including patient adherence, reductions in avoidable utilization and revenue optimization.
Those use cases are intended to demonstrate how predictive intelligence can be applied across clinical, operational and financial workflows.
WellStack’s platform will serve as the underlying healthcare data foundation, while DeLorean AI adds predictive modeling and recommended actions.
The combination also reflects a broader shift in healthcare technology toward systems that not only centralize information but actively help users decide what to do with it.
DeLorean AI believes this next stage of healthcare AI will require deeper integration with healthcare organizations’ data lakes and electronic medical record systems.
The acquisition is intended to give WellStack a more complete platform spanning healthcare data infrastructure, AI-driven prediction and operational decision support.
KEY QUOTES:
“The acquisition of DeLorean AI is not just about what we can achieve today. It’s about building the foundation for the next generation of healthcare innovation. By combining WellStack’s health data platform with DeLorean AI’s advanced AI capabilities, we are expanding our ability to serve clients and accelerate product innovation.”
“Together with DeLorean AI, WellStack is redefining what’s possible for healthcare organizations seeking smarter decisions, greater efficiency, and a competitive advantage in an increasingly complex market.”
Rich Waller, CEO Of WellStack
“The artificial intelligence market is evolving rapidly, and we believe that healthcare is on the cusp of an additional asymmetric evolution. This will require deep integration with a healthcare institution’s data lake or the EMR. To stay ahead of this shift, we believe merging with WellStack best positions our joint capabilities to more seamlessly drive enhanced quality, decrease costs, and deliver better health outcomes for the patients we support.”
Severence MacLaughlin, CEO Of DeLorean Artificial Intelligence
